Jump to content

Bertha Madras

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by ApApedia (talk | contribs) at 23:01, 16 November 2024. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Bertha Kalifon Madras is a professor of psychobiology in the Department of Psychiatry and the chair of the Division of Neurochemistry at Harvard Medical School, Harvard University. She served as associate director for public education in the division on Addictions at Harvard Medical School. Madras has published research in the areas of drug addiction (particularly the effects of cocaine), ADHD, and Parkinson's disease.

Madras earned a BSc in biochemistry with honours from McGill University in 1963.[1][2] As a J.B. Collop Fellow of the Faculty of Medicine, she earned a PhD in biochemistry (metabolism and pharmacology, including hallucinogens) from McGill University in 1967.[1][2] She completed postdoctoral fellowships in biochemistry at Tufts University/Cornell University Medical College (1966–1967) as well as at the Massachusetts Institute of Technology (1967–1969).[1][2] Thereafter, she was appointed a research associate at the Massachusetts Institute of Technology (1972–1974) as well as an assistant professor in the Departments of Pharmacology and Psychiatry at the University of Toronto.[1][2] Dr Madras joined the Harvard Medical School as an assistant professor in 1986 and was subsequently promoted to associate professor and (full) professor – with a cross-appointment to the Department of Psychiatry at the Massachusetts General Hospital.[1] Dr Madras also founded and chaired the Division of Neurochemistry at Harvard Medical School's New England Primate Research Centre – a multidisciplinary, translational research program which spans chemical design, molecular and cellular biology, behavioural biology, and brain imaging approaches.[1] She directs the Laboratory of Addiction Neurobiology, McLean Hospital, in conjunction with the Harvard Brain Science initiative.[3]

Personal life

[edit]

She is married to Peter Madras and has two daughters, two sons-in-law, and five grandchildren.[citation needed].

Public policy work

[edit]

Madras served as the deputy director for demand reduction for the White House Office of National Drug Control Policy;[4] She was nominated by President George W. Bush in July, 2005, and unanimously confirmed by the United States Senate in 2006.[5][6][7] In the federal budget for Medicaid reimbursement, assurances that the majority of federal employees' healthcare insurers would reimburse for these procedures, that certain State Medicaid plans would reimburse for SBI services, that the Veterans' Administration would mandate SBI for alcohol throughout the VA system,[8] and that the Federal Health Resource Services Administration (HRSA) would implement these services in the underserved populations.[9][10][11][12][13][14][15][16][17][18]

Research

[edit]

Madras has authored over 130 scientific manuscripts and book chapters, and she recently co-edited a book on the Cell Biology of Addiction.[19] Along with her collaborators, she is the recipient of 19 patents.[20]

Honours

[edit]

Her co-discovery of altropane was recognized by the Association of University Technology Managers in 2006.[21]

References

[edit]
  1. ^ a b c d e f "United States of America v. Schweder, et al. (2014). "Declaration of Bertha Madras, Ph.D". Case No. 2:11-CR-00449-KJM-16, in the United States District Court – Eastern District of California. Page 2" (PDF). Archived (PDF) from the original on April 17, 2018. Retrieved August 8, 2017.
  2. ^ a b c d "Bertha K. Madras, PHD | McLean Hospital". Archived from the original on August 8, 2017. Retrieved August 8, 2017.
  3. ^ "Bertha Madras". Harvard Brain Science Initiative. Archived from the original on August 10, 2022. Retrieved August 10, 2022.
  4. ^ "Bertha Madras, Deputy Director for Demand Reduction, White House Office of National Drug Control Policy – ONDCP". Archived from the original on August 7, 2007. Retrieved 2008-01-15.
  5. ^ "Office of National Drug Control Policy | The White House". Whitehousedrugpolicy.gov. Archived from the original on May 16, 2008. Retrieved October 19, 2011.
  6. ^ "Aphsa Health Services Division" (PDF). Nasmd.org. Retrieved October 19, 2011.[permanent dead link‍]
  7. ^ http://staging.whitehousedrugpolicy.gov/about/madras.html[permanent dead link‍]
  8. ^ "Archived copy". Archived from the original on May 10, 2009. Retrieved May 4, 2009.{{cite web}}: CS1 maint: archived copy as title (link)
  9. ^ [1] Archived December 31, 2008, at the Wayback Machine
  10. ^ Stephanie Whyche (May 16, 2008). "Federal Workers Get Coverage for Substance Abuse Screening". Pn.psychiatryonline.org. Archived from the original on July 29, 2012. Retrieved October 19, 2011.
  11. ^ "National strategy focuses on screening: ONDCP demand reduction chief urges early intervention. (Office of National Drug Control Policy)". Alcoholism & Drug Abuse Weekly. February 19, 2007. Archived from the original on October 16, 2012. Retrieved April 13, 2009.
  12. ^ Tim Caron; Matt Gever; Allison Colker (July 15, 2008). "NCSL Substance Abuse Snapshot, July 15, 2008". Ncsl.org. Archived from the original on September 8, 2012. Retrieved October 19, 2011.
  13. ^ "National Institute on Drug Abuse to Unveil NIDAMED, Physicians' Outreach Initiative, April 6, 2009 News Release – National Institutes of Health (NIH)". Nih.gov. Archived from the original on February 18, 2012. Retrieved October 19, 2011.
  14. ^ "Instituto De Salud Del Estado De México". Salud.edomexico.gob.mx. Archived from the original on October 7, 2011. Retrieved October 19, 2011.
  15. ^ "Addictologia Hungarica – What Works to Reduce Drug Use". Archived from the original on January 23, 2008.
  16. ^ Madras, BK; Compton, WM; Avula, D; Stegbauer, T; Stein, JB; Clark, HW (January 2009). "Drug and Alcohol Dependence : Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later". Drug Alcohol Depend. 99 (1–3): 280–95. doi:10.1016/j.drugalcdep.2008.08.003. PMC 2760304. PMID 18929451.
  17. ^ Madras, BK; Compton, WM; Avula, D; Stegbauer, T; Stein, JB; Clark, HW (January 2009). "Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later". Drug Alcohol Depend. 99 (1–3): 280–95. doi:10.1016/j.drugalcdep.2008.08.003. PMC 2760304. PMID 18929451.
  18. ^ Bertha K. Madras: Office of National Drug Control Policy: A scientist in drug policy in Annals of the New York Academy of Sciences, 1187: Addiction Reviews 2; pages 370–402, 2010.
  19. ^ Madras BK. Introduction to "Cell Biology of Addiction". Editors: Madras BK, Colvis CM, Pollack JD, Rutter JL, Shurtleff D, von Zastrow M, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 1–12, 2006.
  20. ^ "United States Patent and Trademark Office". Uspto.gov. December 1, 1994. Archived from the original on February 1, 2018. Retrieved October 19, 2011.
  21. ^ Association of University Technology Managers 2006 Better World Reports: "Technology Transfer Stories: 25 Innovations That Changed the World"[dead link‍]
[edit]

PubMed search for articles by Bertha Madras

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bertha_Madras&oldid=1257848017"